Prevalence of Ocular Morbidity among Thyroid Patient in Northwest Uttar Pradesh India


Authors : Purushottam Kumar Jha; Dr. Pinaki Adak; Rakesh Kumar Yadav

Volume/Issue : Volume 10 - 2025, Issue 6 - June


Google Scholar : https://tinyurl.com/5n89872x

DOI : https://doi.org/10.38124/ijisrt/25jun108

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Aim: To assess the prevalence of ocular morbidity among thyroid patients in northwest Uttar Pradesh, India  Method: A Prospective cross-sectional study was conducted among patients presenting with thyroid eye disease approaching Department of Ophthalmology, Teerthanker Mahaveer Hospital and Research Centre Moradabad (U.P) India. A total of 50 patients were included in the study. All patients underwent detailed ophthalmic evaluation and thyroid eye disease workup with dry eye. Patients were categorized into Euthyroid, Hypothyroid, and Hyperthyroid according to their thyroid levels.  Result: Mean age of Hypothyroid patient were 42.1±15.48, mean age of Hyperthyroid patient were 13.3±8.62 and mean age of Euthyroid patients 41.68±14.32. All three groups were divided into grades from Grade0-GradeVI according to the severity of disease,100% Euthyroid were in grade 0 and hypothyroid in Grade I same as in Hyperthyroid 66.60% patient were in Grade I and 33.30% in Grade II.62% of patients were taking medicine out of them 56% were taking thyroxin and 6% were taking Thyrocab. Dry eyes were also related to a thyroid disease, 100% Euthyroid patients were suffering from mild dry eye while hypothyroid and hyperthyroid patients were suffering from moderate dry eye.  Conclusion: Visual morbidities may manifest months after thyroid illness or thyroid eye disease first appears. Males and old age participants are linked with visual morbidity in TED. After receiving therapy for their ocular issues, a considerable percentage of TED patients achieve excellent vision. In individuals with systemic thyroid disease, we advise routine complete eye examinations.

Keywords : Euthyroid, Hypothyroid, Hyperthyroid, Thyroid Eye Disease, Ocular Symptoms.

References :

  1. Stan M, Bahn R. Risk factors for development or deterioration of Graves’ ophthalmopathy. Thyroid 2010;20:777e83.
  2. Niffenegger JH, Fong D, Cavallerano J, Diabetes mellitus. In:Jakobiec FA, Albert DM, editor. Principles and practice of ophthalmology: Basic sciences. Vol5. Philadelphia: WB Saunders; 1994. p. 2925‑36.
  3. Greco D, Pisciotta M, Gambina F, Maggio F. Graves’ disease in subjects with type 1 diabetes mellitus: A prevalence study in Western Sicily (Italy). Prim Care Diabetes 2011;5:241e4.
  4. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am OphthalmolSoc 1994;92:477‑588.
  5. Blandford AD, Zhang D, Chundury RV, Perry JD. Dysthyroid optic neuropathy: Update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmology 2017;12:111‑21.
  6. Reddy SV, Jain A, Yadav SB, Sharma K, Bhatia E. Prevalence of Graves’ ophthalmopathy in patients with Graves’ disease presenting to a referral Centre in north India. Indian J Med Res 2014;139:99‑104.
  7. V. D. Castagno, A. G. Fassa, M. L. V. Carret, M. A. P. Vilela, and R. D. Meucci,  “Hyperopia: a meta-analysis of prevalence and a review of associated factors among  school-aged children,”BMCOphthalmology, vol.  14, no. 1, p. 163, 2014
  8. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev. 2003 Dec; 24(6):802–35. [PubMed: 14671007]
  9. P. J. Foster and Y. Jiang, “Epidemiology of myopia,” Eye,  vol. 28, no. 2, pp. 202– 208, 2014.
  10. McKenzie JM, Zakarija M, Sato A. Humoral immunity in Graves’ disease. Clin Endocrinol Metab.1978 Mar; 7(1):31–45. [PubMed: 580600]
  11. Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cellchemo attractant expression in fibroblasts from patients with Graves’ disease is mediated throughthe insulin-like growth factor I receptor pathway. J Immunol. 2003 Jun 15; 170(12):6348–54.[PubMed: 12794168]
  12. Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinham Hikim A, et al. Evidence for anassociation between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ disease. J Immunol. 2008 Sep 15; 181(6):4397–405.[PubMed: 18768899]
  13. Smith TJ, Koumas L, Gagnon A, Bell a, Sempowski GD, Phipps RP, et al. Orbital fibrob last the terogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. The Journal of clinical endocrinology and metabolism. 2002 Jan; 87(1):385–92. [PubMed: 11788681]

Aim: To assess the prevalence of ocular morbidity among thyroid patients in northwest Uttar Pradesh, India  Method: A Prospective cross-sectional study was conducted among patients presenting with thyroid eye disease approaching Department of Ophthalmology, Teerthanker Mahaveer Hospital and Research Centre Moradabad (U.P) India. A total of 50 patients were included in the study. All patients underwent detailed ophthalmic evaluation and thyroid eye disease workup with dry eye. Patients were categorized into Euthyroid, Hypothyroid, and Hyperthyroid according to their thyroid levels.  Result: Mean age of Hypothyroid patient were 42.1±15.48, mean age of Hyperthyroid patient were 13.3±8.62 and mean age of Euthyroid patients 41.68±14.32. All three groups were divided into grades from Grade0-GradeVI according to the severity of disease,100% Euthyroid were in grade 0 and hypothyroid in Grade I same as in Hyperthyroid 66.60% patient were in Grade I and 33.30% in Grade II.62% of patients were taking medicine out of them 56% were taking thyroxin and 6% were taking Thyrocab. Dry eyes were also related to a thyroid disease, 100% Euthyroid patients were suffering from mild dry eye while hypothyroid and hyperthyroid patients were suffering from moderate dry eye.  Conclusion: Visual morbidities may manifest months after thyroid illness or thyroid eye disease first appears. Males and old age participants are linked with visual morbidity in TED. After receiving therapy for their ocular issues, a considerable percentage of TED patients achieve excellent vision. In individuals with systemic thyroid disease, we advise routine complete eye examinations.

Keywords : Euthyroid, Hypothyroid, Hyperthyroid, Thyroid Eye Disease, Ocular Symptoms.

CALL FOR PAPERS


Paper Submission Last Date
30 - June - 2025

Paper Review Notification
In 2-3 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe